SenesTech Inc (SNES) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SenesTech Inc (SNES) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.38 Million) by net assets ($11.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SNES market cap for the company's overall valuation and market capitalisation.
SenesTech Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how SenesTech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
SenesTech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SenesTech Inc ranked by their cash flow conversion efficiency. See SNES cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
International Biotechnology Trust plc
LSE:IBT
|
0.126x |
|
CF Energy Corp
V:CFY
|
0.026x |
|
Baillie Gifford European Growth Trust PLC
LSE:BGEU
|
-0.001x |
|
Accelerate Resources Ltd
AU:AX8
|
-0.037x |
|
Strategem Capital Corp
V:SGE
|
0.008x |
|
Traka Resources Ltd
AU:TKL
|
6.791x |
|
Munic SA
PA:ALMUN
|
0.139x |
|
Big Tree Cloud Holdings Limited Ordinary Shares
NASDAQ:DSY
|
-0.225x |
Annual Cash Flow Conversion Efficiency for SenesTech Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of SenesTech Inc from 2014 to 2024. View SenesTech Inc (SNES) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.51 Million | $-6.03 Million | -2.403x | -101.68% |
| 2023-12-31 | $6.35 Million | $-7.57 Million | -1.191x | +26.68% |
| 2022-12-31 | $5.28 Million | $-8.58 Million | -1.625x | -109.59% |
| 2021-12-31 | $10.04 Million | $-7.78 Million | -0.775x | +57.64% |
| 2020-12-31 | $3.88 Million | $-7.11 Million | -1.830x | +41.70% |
| 2019-12-31 | $2.57 Million | $-8.06 Million | -3.139x | -117.11% |
| 2018-12-31 | $6.31 Million | $-9.13 Million | -1.446x | -16.68% |
| 2017-12-31 | $7.52 Million | $-9.32 Million | -1.239x | -100.37% |
| 2016-12-31 | $10.83 Million | $-6.70 Million | -0.618x | -164.88% |
| 2015-12-31 | $-3.85 Million | $-3.67 Million | 0.953x | +115.91% |
| 2014-12-31 | $-5.72 Million | $-2.53 Million | 0.441x | -- |
About SenesTech Inc
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning wit… Read more